Does LEVOMILNACIPRAN Cause Withdrawal syndrome? 22 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Withdrawal syndrome have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 1.6% of all adverse event reports for LEVOMILNACIPRAN.
22
Reports of Withdrawal syndrome with LEVOMILNACIPRAN
1.6%
of all LEVOMILNACIPRAN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Withdrawal syndrome From LEVOMILNACIPRAN?
Of the 22 reports, 6 (27.3%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Withdrawal syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does LEVOMILNACIPRAN Cause?
Off label use (376)
Drug ineffective (315)
Gastrooesophageal reflux disease (295)
Vomiting (294)
Hypoaesthesia (290)
Abdominal pain upper (285)
Paraesthesia (282)
Memory impairment (277)
Blepharospasm (276)
Taste disorder (276)
What Other Drugs Cause Withdrawal syndrome?
ACETAMINOPHEN\OXYCODONE (4,046)
PREGABALIN (3,329)
OXYCODONE (2,798)
ACETAMINOPHEN\HYDROCODONE (2,636)
FENTANYL (1,948)
MORPHINE (1,674)
TRAMADOL (1,582)
VENLAFAXINE (1,516)
DULOXETINE (1,328)
BUPRENORPHINE (1,266)
Which LEVOMILNACIPRAN Alternatives Have Lower Withdrawal syndrome Risk?
LEVOMILNACIPRAN vs LEVONORGESTREL
LEVOMILNACIPRAN vs LEVORPHANOL
LEVOMILNACIPRAN vs LEVOSIMENDAN
LEVOMILNACIPRAN vs LEVOSULPIRIDE
LEVOMILNACIPRAN vs LEVOTHYROXINE